Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism SPNS2 inhibitors(sphingolipid transporter 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Dermatomyositis | Discovery | - | 03 Oct 2024 | |
| Dermatomyositis | Discovery | - | 03 Oct 2024 | |
| Immune System Diseases | Discovery | - | 03 Oct 2024 | |
| Immune System Diseases | Discovery | - | 03 Oct 2024 | |
| Neoplasms | Discovery | - | 03 Oct 2024 | |
| Neoplasms | Discovery | - | 03 Oct 2024 | |
| Urogenital Diseases | Discovery | - | 03 Oct 2024 | |
| Urogenital Diseases | Discovery | - | 03 Oct 2024 |





